Miguel Casanovas

11PUBLICATIONS
37CO-AUTHORS
AllergyDisease surveillanceGene and molecular therapyMedical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
Real-World Effectiveness and Safety of Allergen Immunotherapy with a Combination of Glutaraldehyde-Polymerized Allergen Extracts of Dermatophagoides spp. and Lepidoglyphus destructor in Adults and Children.

|Aug 27, 2026
Real-World Effectiveness of Polymerized House-Dust-Mite Subcutaneous Immunotherapy up to 24 Months: Why Baseline Symptom Severity Shapes Measurement of the Combined Symptom-Medication Response.

|Jul 28, 2026
Subcutaneous Immunotherapy with Mannan-Conjugated Birch Pollen Allergoids in a Pre- and Co-Seasonal Treatment Regimen: An Exploratory Post Hoc Subgroup Analysis of Safety and Tolerability.

|Apr 30, 2026
Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.

|Dec 11, 2025
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.

Sandra Del Pozo, Natascha Wahrhusen, Oliver Pfaar

|Nov 09, 2024
Short-course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy.

Ralph Mösges, Esther Raskopf, Ludger Klimek

Pageof 2

Frequent Collaborators

8 joint publications

José Luis Subiza

6 joint publications

Sandra Del Pozo Collado

4 joint publications

Anna Rybachuk

4 joint publications

Mandy Cuevas